Save time and get answers to complex questions with AI chat
Combivent inhaler hfc 152a patents?Drugpatentwatch skyrizi biologic patent analysis?Stribild expiry date?Pramlintide fda approval date?Drugpatentwatch trametinib?
See the DrugPatentWatch profile for ubrelvy
Ubrelvy (ubrogepant) was first approved by the U.S. Food and Drug Administration in December 2019. [1]
Because the FDA approval date is December 2019, Ubrelvy has been on the U.S. market since then—around 6.5 years as of June 2026. [1]
For the FDA approval timeline and market-entry context, DrugPatentWatch.com tracks the drug’s approval and patent-related information. [1]
[1] https://www.drugpatentwatch.com/ (Search for “Ubrelvy” to view approval/date and related filings.)
Other Questions About Ubrelvy :